SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the November 22 target date and the companys amended application emphasizing upper-limb function data. Bullish traders interpret the longer-term data, rare-disease policy discussions and recent commercial hiring as encouraging signs, while skeptics cite prior FDA concerns and say approval remains uncertain.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention for its breakout ahead of the expected Q3 earnings report, with traders focused on BRIUMVIs growth and possible further upside. Buyout and short-squeeze chatter is prominent but speculative; some traders instead attribute the move to earnings expectations and the companys commercial momentum.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall after early 2027 has fueled a sharp selloff and concern about future pricing and revenue. Traders disagree over whether the warning signals sustained pressure or is only a preliminary estimate, pointing to CMSs more stable outlook while criticizing CorMedixs lack of clarification.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp Nasdaq selloff tied to weakness in technology and semiconductor stocks, with traders debating whether concerns about AI spending and earnings justify more downside or whether the decline is an oversold dip to buy. The late-session rebound prompted some dip-buying optimism, but bearish traders continued to warn that the correction may not be over.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS REGAL Phase 3 leukemia trial reached its prespecified event threshold, triggering final analysis and putting the GPS survival readout in focus. Traders are sharply divided over whether GPS will show a benefit or whether control-arm outcomes and trial assumptions could undermine the bull case, amid volatile trading and speculation about short positioning.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigens PAPZIMEOS commercial launch and stronger-than-expected quarterly results, including a move to profitability, are driving bullish discussion about its growth prospects. Traders also debate whether potential INO-3107 competition could challenge PAPZIMEOS and whether heavy short interest is amplifying the stocks moves.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported major Binance security breach and temporary withdrawal suspension have fueled Bitcoin selling and concerns about crypto exchange security. Traders disagree over whether the incident signals broader risk or is isolated to Binance, with some viewing the pullback as a buying opportunity and others warning of further downside.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

ARM is caught in a sharp semiconductor and AI-stock selloff, with traders citing its rich valuation and questioning whether AI demand can support the growth priced in. Some see the drop as an overdone sector-driven correction and are buying the dip, while others expect further downside.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its quarterly report is fueling concern about slowing ad growth, analyst target cuts, and weakness across advertising-related stocks. Traders debate whether the decline reflects deteriorating prospects or has overshot the companys growth and cash-generation fundamentals, with earnings seen as a key test.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

Silvers sharp selloff, amid inflation concerns and expectations of higher interest rates, is driving attention to SLV. Traders are split between calling the decline an oversold buying opportunity and warning that selling may continue, with some blaming market manipulation without evidence.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FatPipe, Inc. (NASDAQ: FATN) is Pleased to Announce Its Investor Webinar on November 4 to Present Q2 Financial Results

FatPipe, Inc. (NASDAQ: FATN) is Pleased to Announce Its Investor Webinar on November 4 to Present Q2 Financial Results FatPipe, Inc. (NASDAQ: FATN) is Pleased to Announce Its Investor Webinar on November 4 to Present Q2 Financial ResultsPR NewswireSALT LAKE CITY, Oct. 16, 2026 SALT LAKE CITY, Oct...

Fatpipe Reports Q1 2027 Results: Full Earnings Call Transcript

On Thursday, Fatpipe (NASDAQ:FATN) discussed first-quarter financial results during its earnings call. The full transcript is provided below.
This transcript is brought to you by Benzinga APIs. For real-time access toread more...

FatPipe, Inc. (FATN) Reports Q1 FY2027 Results: 28% Y-o-Y Q1 Revenue Growth and 25.6% Adjusted EBITDA Margin

FatPipe, Inc. (FATN) Reports Q1 FY2027 Results: 28% Y-o-Y Q1 Revenue Growth and 25.6% Adjusted EBITDA Margin FatPipe, Inc. (FATN) Reports Q1 FY2027 Results: 28% Y-o-Y Q1 Revenue Growth and 25.6% Adjusted EBITDA Margin PR Newswire SALT LAKE CITY, July 30, 2026 SALT LAKE CITY, July 30, 2026...

FatPipe, Inc. (NASDAQ: FATN) is Pleased to Announce Its Investor Webinar to Present Q1 Financial Results on July 30

FatPipe, Inc. (NASDAQ: FATN) is Pleased to Announce Its Investor Webinar to Present Q1 Financial Results on July 30 FatPipe, Inc. (NASDAQ: FATN) is Pleased to Announce Its Investor Webinar to Present Q1 Financial Results on July 30 PR Newswire SALT LAKE CITY, July 6, 2026 SALT LAKE CITY, July 6...

FatPipe Announces SATBoost for Starlink, Viasat and Amazon LEO: Up to 300% Faster Data Flow and Better Connectivity

FatPipe Announces SATBoost for Starlink, Viasat and Amazon LEO: Up to 300% Faster Data Flow and Better Connectivity FatPipe Announces SATBoost for Starlink, Viasat and Amazon LEO: Up to 300% Faster Data Flow and Better Connectivity PR Newswire SALT LAKE CITY, June 11, 2026 SALT LAKE CITY, June 11...

Is FatPipe (FATN) One of the Hot Tech Stocks to Buy According to Analysts?

Is FatPipe (FATN) One of the Hot Tech Stocks to Buy According to Analysts...

FatPipe Inc. (FATN) Reports Q4 and FY2026 Results: 90% Y-o-Y Q4 Revenue Growth, Q4 Recurring Revenue up 56% Y-o-Y, Annual Revenue Growth of 18%

FatPipe Inc. (FATN) Reports Q4 and FY2026 Results: 90% Y-o-Y Q4 Revenue Growth, Q4 Recurring Revenue up 56% Y-o-Y, Annual Revenue Growth of 18% FatPipe Inc. (FATN) Reports Q4 and FY2026 Results: 90...

Why FatPipe Stock Is Surging On Friday?

FatPipe Inc. (NASDAQ: FATN) reports a 79% YoY revenue surge and significant Adjusted EBITDA growth in its preliminary Q4 results.read more...

FatPipe, Inc. Provides Preliminary Fourth Quarter Fiscal 2026 Results and Business Update; Schedules Earnings Release for May 18th, 2026

FatPipe, Inc. Provides Preliminary Fourth Quarter Fiscal 2026 Results and Business Update; Schedules Earnings Release for May 18th, 2026 FatPipe, Inc. Provides Preliminary Fourth Quarter Fiscal 2026...

These Stocks Are Riding Mega Trends

These Stocks Are Riding Mega Trends $TGNT, $AKAN, $HTZ, $UBER, $FATN, $ABTS, $HCAI

FatPipe, Inc. engages in the development of software-defined wide area network (SD-WAN) solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. Its products include WARP, MPVPN, SD-WAN, Fatpipe Orchestrator, Next Gen Firewall, 5G and LTE, FatPipe Total Security 360, SASE, SIEM, EnterpriseView, and Cloud Connect. The company was founded by Ragula Bhaskar and Sanchaita Datta on October 14, 2010 and is headquartered in Salt Lake City, UT.

Fatpipe Inc.

Retail Traders Flock To FatPipe As Shares Leap 28% Days After Market Debut

Equity

Neutral Sentiment

Newly listed FatPipe, Inc. (FATN) stock has seen volatility since its public debut on April 8, understandably so as the broader market swings wildly to the tariff news flow.Salt Lake City, Utah-based FatPipe develops software-defined wide area networks (SD-WAN), secure access service edge (SASE), and network monitoring services (NMS).Its customers include enterprises, communication service providers, security service providers, government organizations, and middle-market companies.FatPipe offered 695,656 shares of its common stock in an underwritten initial public offering (IPO) priced at $5.75 apiece last week. Following the closing of the offering, the company said it received gross proceeds of $4 million.The stock opened for trading on April 8 at $6.50 and moved in a $6.50 to $23.27 range before settling at $13, up 200% from the IPO price. The stock hit a post-IPO low of $5.60 on Friday but ended higher for the day at $6.36.The upward momentum carried over into Monday’s session as the stock jumped 27.52% before settling at $8.11.FatPipe was among the top 15 trending tickers and the top 25 active tickers on Stocktwits early Tuesday.The seven-day change in follower count is about 1,000%, highlighting the retail interest in FatPipe stock. It has already risen to 1,444 followers.&nbsp;Retail chatter has also perked up, with the 24-hour message volume up by 4,900%.Retail sentiment toward FatPipe stock was ‘bullish’ (55/100), and the message volume stayed ‘high.’<figure class="image"><img style="aspect-ratio:638/141;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_15_at_3_20_52_AM_png_10750ff06f.webp" alt="Screenshot 2025-04-15 at 3.20.52 AM.png" width="638" height="141"><figcaption>FATN sentiment and message volume as of 3:21 a.m. ET, April 15 | source: Stocktwits</figcaption></figure>A bullish watcher said they were looking for a run in FatPipe stock to over $15 by this week following its recent consolidation around the $10 level.<stembedurl>https://stocktwits.com/EZ_Money11/message/611651057</stembedurl>Another user called it a clean “multi-day runner” without any pump or dump.<stembedurl>https://stocktwits.com/oscar89/message/611616416</stembedurl>Still, FatPipe stock is down about 38% from its closing price in the debut session&nbsp;last week.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/hubspot-analyst-slashes-stock-price-target-by-over-20-percent/chQR2tTRbaV">&nbsp;HubSpot Analyst Slashes Stock Price Target By Over 20% On Choppy H1 View, But Retail Stays Upbeat</a>

Rising stock market chart on a trading board background.

FatPipe offered 695,656 shares of its common stock in an underwritten initial public offering priced at $5.75 apiece last week.

FatPipe, Inc. Common Stock

iShares Micro-Cap ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$5.10
Prev Close	$5.30
Open	$5.19
Dividend Yield	0.00%
50-Day Moving Average	$5.52
Beta	0.00
Avg. Volume	73,694.74
PE Ratio	13.64

52-Week High	$8.61
52-Week Low	$1.31
Market Capitalization	$74.88M
EPS (Annual)	$0.3544
Price to Book	2.82
Revenue Per Employee	$111,676.13

Feed

News

Sentiment

Earnings

Fundamentals

Info

FATN Fundamentals